CHINDEX INTERNATIONAL ANNOUNCES Award of 8.1 Million Euros in German Financed Hospital Supply Packages And Planned Participation in New Ex-Im Project Under Recently-Signed Framework

Chindex also announced that it intends to reinstitute its financing programs for Chinese hospitals backed by the Export-Import Bank of the United States under the new framework agreement which was signed by the Bank and the Chinese Ministry of Finance on January 24, 2005 .

Chindex China-Export GmbH submitted the winning bids for two components of the Health Program and HIV Prevention II Component project funded by KfW, providing the financing for Chindex to supply 5.1 million euros of primarily German medical equipment to hospitals in Inner Mongolia and Shaanxi provinces. In early 2004, Chindex China-Export GmbH was awarded a component of the Health Program and HIV Prevention I Component project funded by KfW, and is providing 3.0 million euros in financing for hospitals in Anhui Province to purchase primarily German medical equipment from Chindex. The KfW has committed to ongoing programs for financing medical equipment purchases by Chinese hospitals. Chindex intends to continue as a supplier for these programs and is one of only three companies that to date have been accepted as suppliers.

The completion of the Framework Agreement between the Export-Import Bank of the United States and the Chinese Ministry of Finance culminates over two years of negotiation between the two parties, during which time U.S.-Government supported financing packages for medical equipment purchases were unable to be processed through the Chinese system. Now that the mechanism under which these loan programs may proceed has been finalized, Chindex will move ahead with its next planned Ex-Im Bank sponsored loan project.

"Chindex is thrilled with both of these developments that will have positive impact on our capital medical equipment sales in China ," Chindex President and CEO Roberta Lipson commented from Beijing . "The hospital market in China relies increasingly on foreign government-sponsored financing to make purchases of medical equipment. The addition over the past couple of years of our access to German Government financing through our German subsidiary has provided yet another program that we are able to offer to our hospital customers. With Ex-Im Bank financing available again, we now have an even larger basket of financing options to offer to cash-strapped hospitals in need of top quality Western medical technologies. Chindex continues to look for even more financing alternatives to offer to our hospital customers, including from other European governments," Lipson concluded.

About Chindex

Chindex is an American company operating in several healthcare sectors of the Chinese marketplace, including Hong Kong . It provides representative and distribution services to a number of major multinational companies including Siemens AG (ultrasound systems), and Guidant (interventional cardiology products including stents, balloon catheters and guide wires). Its distribution channels to the retail pharmacy industry in China have been developed through a relationship with a major multinational cosmetics manufacturer. It also provides healthcare services through the operations of its two private hospitals in China . With twenty-three years of experience, over 800 employees, and operations in the United States , China and Hong Kong , the Company's strategy is to expand its cross-cultural reach by providing leading edge technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites www.chindex.com and www.unitedfamilyhospitals.com .

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties pertaining to the Company's (i) introduction of new products, including the products described in this release, (ii) performance goals, including successful conclusion of efforts to secure government-backed financing and successful implementation of such financing, (iii) future events and earnings, including revenues from the Company's developmental businesses such as healthcare services, (iv) markets, including growth in demand in China for the Company's products and services, and (v) proposed new operations, including expansion of its healthcare services business. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events .

# # #